Coherus Biosciences share price today

(CHRS)

Coherus Biosciences share price is $1.47 & ₹125.24 as on 25 Dec 2024, 2.30 'hrs' IST

$1.47

▲

0.04

(2.8%)

Market is closed - opens 8 PM, 26 Dec 2024

View live Coherus Biosciences share price in Dollar and Rupees. Guide to invest in Coherus Biosciences from India. Also see the sentimental analysis on Indian investors investing in Coherus Biosciences. Get details on the Indian mutual funds that are investing in Coherus Biosciences. Get Analyst recommendations and forecasts along with all the Coherus Biosciences's financials.

Coherus Biosciences share price movements

Today's Low: $1.36
Today's High: $1.48
$1.47
7.82%
Downside
Day's Volatility :8.45%
Upside
0.68%
52 Weeks Low: $0.66
52 Weeks High: $3.70
$1.47
55.08%
Downside
52 Weeks Volatility :82.15%
Upside
60.27%

Coherus Biosciences Returns

Period	Coherus Biosciences Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	38.68%	-9.0%	0.0%
6 Months	-13.53%	-4.6%	0.0%
1 Year	-45.35%	3.0%	0.0%
3 Years	-91.69%	0.0%	-21.1%

Coherus Biosciences Key Statistics

in dollars & INR

Previous Close	$1.43
Open	$1.45
Today's High	$1.48
Today's Low	$1.355
Market Capitalization	$169.4M
Today's Volume	$1.1M
52 Week High	$3.7
52 Week Low	$0.6603
Revenue TTM	$304.3M
EBITDA	$-116.9M
Earnings Per Share (EPS)	$-0.09
Profit Margin	-0.15%
Quarterly Earnings Growth YOY	-0.75%
Return On Equity TTM	-1657.06%

How to invest in Coherus Biosciences from India?

It is very easy for Indian residents to invest directly in Coherus Biosciences from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Coherus Biosciences stock in both Indian Rupees (INR) and US Dollars (USD). Search for Coherus Biosciences or CHRS on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Coherus Biosciences or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Coherus Biosciences shares which would translate to 0.580 fractional shares of Coherus Biosciences as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Coherus Biosciences, in just a few clicks!

Returns in Coherus Biosciences for Indian investors in Rupees

Investment Value

₹1,00,000

Coherus Biosciences investment value today

Current value as on today

₹56,885

Returns

₹43,115

(-43.11%)

Returns from Coherus Biosciences Stock

₹45,353 (-45.35%)

Dollar Returns

₹2,239 (+2.24%)

Indian investors sentiment towards Coherus Biosciences

76.92%

Period: Sep 26, 2024 to Dec 25, 2024. Change in 30 Days versus previous period

Investment in Coherus Biosciences from India has grown in the last 30 days as on Dec 26, 2024. 76.92% more purchase transactions for Coherus Biosciences in the last 30 days versus the previous period.

56%

Period: Sep 26, 2024 to Dec 25, 2024. Change in 30 Days versus previous period

Search volume for Coherus Biosciences on INDmoney from India has grown in the last 30 days as on Dec 26, 2024. 56% more investors are searching Coherus Biosciences in the last 30 days versus the previous period.

Global Institutional Holdings in Coherus Biosciences

BlackRock Inc
10.20%
Vanguard Group Inc
9.82%
Rubric Capital Management LP
9.03%
Kohlberg Kravis Roberts & Co LP
2.64%
Citadel Advisors Llc
2.48%
Geode Capital Management, LLC
2.23%

Analyst Recommendation on Coherus Biosciences

Buy

81%Buy

18%Hold

0%Sell

Based on 16 Wall street analysts offering stock ratings for Coherus Biosciences(by analysts ranked 0 to 5 stars)

Based on 16 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Coherus Biosciences

What analysts predicted

Upside of 301.36%

Current:

$1.47

Target:

$5.90

Insights on Coherus Biosciences

Price Movement
In the last 1 month, CHRS stock has moved up by 14.8%
Increasing Revenue
Revenue is up for the last 2 quarters, 64.97M → 70.77M (in $), with an average increase of 8.2% per quarter
Increasing Net Profit
Netprofit is up for the last 2 quarters, -12.92M → -10.75M (in $), with an average increase of 20.2% per quarter
CHRS vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 27.2% return, outperforming this stock by 59.8%
CHRS vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 25.2% return, outperforming this stock by 116.9%
Price to Sales
ForCHRS every $1 of sales, investors are willing to pay $0.5, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.7 for every $1 of sales.

Coherus Biosciences Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$1.6M	↑ 0.0%
Net Income	$-209.3M	↓ 12.11%
Net Profit Margin	-13.5K%	↑ 1852.9%

	FY19	Y/Y Change
Revenue	$356.1M	↑ 22783.74%
Net Income	$89.8M	↓ 142.91%
Net Profit Margin	25.23%	↑ 13478.89%

	FY20	Y/Y Change
Revenue	$475.8M	↑ 33.63%
Net Income	$132.2M	↑ 47.21%
Net Profit Margin	27.79%	↑ 2.56%

	FY21	Y/Y Change
Revenue	$326.6M	↓ 31.37%
Net Income	$-306.3M	↓ 331.63%
Net Profit Margin	-93.81%	↓ 121.6%

	FY22	Y/Y Change
Revenue	$211.0M	↓ 35.37%
Net Income	$-326.6M	↑ 6.63%
Net Profit Margin	-154.77%	↓ 60.96%

	FY23	Y/Y Change
Revenue	$257.2M	↑ 21.89%
Net Income	$-237.9M	↓ 27.17%
Net Profit Margin	-92.48%	↑ 62.29%

	Q2 FY23	Q/Q Change
Revenue	$58.7M	↑ 81.02%
Net Income	$-42.9M	↓ 42.67%
Net Profit Margin	-73.01%	↑ 157.54%

	Q3 FY23	Q/Q Change
Revenue	$74.6M	↑ 27.0%
Net Income	$-39.6M	↓ 7.53%
Net Profit Margin	-53.16%	↑ 19.85%

	Q4 FY23	Q/Q Change
Revenue	$91.5M	↑ 22.74%
Net Income	$-79.7M	↑ 100.94%
Net Profit Margin	-87.03%	↓ 33.87%

	Q1 FY24	Q/Q Change
Revenue	$77.1M	↓ 15.8%
Net Income	$102.9M	↓ 229.15%
Net Profit Margin	133.49%	↑ 220.52%

	Q2 FY24	Q/Q Change
Revenue	$65.0M	↓ 15.68%
Net Income	$-12.9M	↓ 112.56%
Net Profit Margin	-19.88%	↓ 153.37%

	Q3 FY24	Q/Q Change
Revenue	$70.8M	↑ 8.92%
Net Income	$-10.8M	↓ 16.79%
Net Profit Margin	-15.19%	↑ 4.69%

	FY18	Y/Y Change
Profit	$1.6M	↑ 0.0%

	FY19	Y/Y Change
Profit	$339.0M	↑ 21686.18%

	FY20	Y/Y Change
Profit	$438.2M	↑ 29.25%

	FY21	Y/Y Change
Profit	$269.0M	↓ 38.62%

	FY22	Y/Y Change
Profit	$141.0M	↓ 47.59%

	FY23	Y/Y Change
Profit	$94.5M	↓ 32.99%

	Q2 FY23	Q/Q Change
Profit	$33.9M	↑ 117.63%

	Q3 FY23	Q/Q Change
Profit	$41.9M	↑ 23.61%

	Q4 FY23	Q/Q Change
Profit	$5.9M	↓ 85.92%

	Q1 FY24	Q/Q Change
Profit	$41.0M	↑ 595.11%

	Q2 FY24	Q/Q Change
Profit	$35.4M	↓ 13.54%

	Q3 FY24	Q/Q Change
Profit	$50.0M	↑ 41.24%

	FY18	Y/Y Change
Operating Cash Flow	$-159.3M	↓ 20.48%
Investing Cash Flow	$-1.2M	↓ 73.1%
Financing Cash Flow	$105.4M	↓ 49.02%

	FY19	Y/Y Change
Operating Cash Flow	$28.4M	↓ 117.8%
Investing Cash Flow	$-12.7M	↑ 971.72%
Financing Cash Flow	$89.4M	↓ 15.23%

	FY20	Y/Y Change
Operating Cash Flow	$154.1M	↑ 443.63%
Investing Cash Flow	$-14.4M	↑ 13.11%
Financing Cash Flow	$223.9M	↑ 150.58%

	FY21	Y/Y Change
Operating Cash Flow	$-37.4M	↓ 124.28%
Investing Cash Flow	$-138.4M	↑ 861.11%
Financing Cash Flow	$51.9M	↓ 76.83%

	FY22	Y/Y Change
Operating Cash Flow	$-241.1M	↑ 544.17%
Investing Cash Flow	$-166.9M	↑ 20.55%
Financing Cash Flow	$54.3M	↑ 4.72%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-38.9M	↓ 43.38%
Investing Cash Flow	$41.4M	↑ 136.02%
Financing Cash Flow	$54.3M	↑ 1328.1%

Coherus Biosciences Technicals Summary

Sell

Neutral

Buy

Coherus Biosciences is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Coherus Biosciences Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Coherus Biosciences Inc	14.84%	-13.53%	-45.35%	-91.69%	-91.62%
Regeneron Pharmaceuticals, Inc.	-5.12%	-32.01%	-18.29%	12.56%	91.19%
Biontech Se	-3.72%	41.99%	6.11%	-55.22%	226.93%
Alnylam Pharmaceuticals, Inc.	-3.99%	-1.52%	23.75%	50.98%	112.09%
Vertex Pharmaceuticals Incorporated	-12.61%	-13.61%	0.03%	83.58%	86.41%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Coherus Biosciences Inc	NA	NA	0.0	-0.86	-16.57	-0.14	NA	-0.76
Regeneron Pharmaceuticals, Inc.	17.67	17.67	1.06	45.07	0.17	0.07	NA	272.04
Biontech Se	160.8	NA	0.04	-3.11	-0.02	-0.01	NA	79.73
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-0.19	-15.01	-0.03	NA	0.25
Vertex Pharmaceuticals Incorporated	32.84	NA	1.06	0.51	-0.03	0.12	NA	60.65

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Coherus Biosciences Inc	Buy	$169.4M	-91.62%	NA	-0.15%
Regeneron Pharmaceuticals, Inc.	Buy	$78.5B	91.19%	17.67	33.61%
Biontech Se	Buy	$27.4B	226.93%	160.8	-15.36%
Alnylam Pharmaceuticals, Inc.	Buy	$31.4B	112.09%	NA	-15.86%
Vertex Pharmaceuticals Incorporated	Buy	$105.1B	86.41%	32.84	-4.51%

About Coherus Biosciences

coherus biosciences is the leading biologics platform company solely focused on delivering high-quality biosimilar therapeutics that will expand patient access to life-changing medicines in regulated markets worldwide. founded in 2010, coherus is a late-stage biologics platform company focused on the global biosimilar market. headquartered in the san francisco bay area and composed of a team of industry veterans with decades of experience in pioneering biologics companies, our goal is to become a global leader in the biosimilar market by leveraging our team's collective expertise in key areas such as process science, analytical characterization, protein production and clinical-regulatory development. our commercialization partnerships include global pharmaceutical companies in europe, asia and latin america. biosimilars are intended for use in place of existing, branded biologics to treat a range of chronic and often life-threatening diseases, with the potential to reduce costs and exp

Organization	Coherus Biosciences
Employees	235
CEO	Mr. Dennis M. Lanfear
Industry	Health Technology

Management People of Coherus Biosciences

Name	Title
Mr. Dennis M. Lanfear	Chairman, President & CEO
Mr. Bryan J. McMichael	Former Interim CFO, Principal Financial and Acc. Off., SVP-Acc. & Corporate Controller
Mr. Paul Reider	Chief Commercial Officer
Mr. Richard L. Hameister	Chief Technical Officer
Ms. Jodi Sievers	Vice President of Investor Relations & Corporate Communications
Mr. Andy Rittenberg	Executive Vice President of General Counsel
Mr. Scott Saywell	Executive Vice President of Corporate Development
Ms. Rebecca Sunshine	Chief Human Resources Officer
Mr. Michael Chen	Senior Vice President of Commercial Analytics & Trade
Dr. Theresa M. Lavallee Ph.D.	Chief Development Officer & Chairman of Scientific Advisory Board

Important FAQs about investing in Coherus Biosciences from India :

What is Coherus Biosciences share price today?

Coherus Biosciences share price today stands at $1.47, Open: $1.45 ; Previous Close: $1.43 ; High: $1.48 ; Low: $1.36 ; 52 Week High: $3.70 ; 52 Week Low: $0.66. The stock opens at $1.45, after a previous close of $1.43. The stock reached a daily high of $1.48 and a low of $1.36, with a 52-week high of $3.70 and a 52-week low of $0.66.

Can Indians buy Coherus Biosciences shares?

Yes, Indians can invest in the Coherus Biosciences (CHRS) from India.

With INDmoney, you can buy Coherus Biosciences at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Coherus Biosciences at zero transaction cost.

How can I buy Coherus Biosciences shares from India?

It is very easy to buy Coherus Biosciences from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Coherus Biosciences be purchased?

Yes, you can buy fractional shares of Coherus Biosciences with INDmoney app.

What are the documents required to start investing in Coherus Biosciences stocks?

To start investing in Coherus Biosciences, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.